Cellphire: Cellphire Therapeutics closes $15M Series A

Long-term stabilization and platelet storage product developer Cellphire Therapeutics announced that it closed a $15 million Series A financing round. Rockville, Md.-based Cellphire develops Thrombosomes and Cryopreserved Platelets (CPP) in bleeding patients. The former is a platelet-based, freeze-dried hemostatic agent, while CPP - frozen platelets - is being developed for the U.S. Army to fill [...] The post Cellphire Therapeutics closes $15M Series A appeared first on Drug Delivery Business.